- Home
- BNR vs DTST Comparison
BNR vs DTST Comparison
Compare BNR & DTST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- DTST
- Stock Information
- Founded
- BNR 2014
- DTST 2001
- Country
- BNR China
- DTST United States
- Employees
- BNR N/A
- DTST N/A
- Industry
- BNR Medical Specialities
- DTST EDP Services
- Sector
- BNR Health Care
- DTST Technology
- Exchange
- BNR Nasdaq
- DTST Nasdaq
- Market Cap
- BNR 29.1M
- DTST 28.2M
- IPO Year
- BNR 2020
- DTST N/A
- Fundamental
- Price
- BNR $3.66
- DTST $3.35
- Analyst Decision
- BNR
- DTST
- Analyst Count
- BNR 0
- DTST 0
- Target Price
- BNR N/A
- DTST N/A
- AVG Volume (30 Days)
- BNR 38.6K
- DTST 40.4K
- Earning Date
- BNR 06-06-2025
- DTST 08-13-2025
- Dividend Yield
- BNR N/A
- DTST N/A
- EPS Growth
- BNR N/A
- DTST N/A
- EPS
- BNR N/A
- DTST 0.02
- Revenue
- BNR $72,112,038.00
- DTST $25,219,312.00
- Revenue This Year
- BNR $136.32
- DTST $12.57
- Revenue Next Year
- BNR N/A
- DTST $9.29
- P/E Ratio
- BNR N/A
- DTST $145.21
- Revenue Growth
- BNR 0.53
- DTST N/A
- 52 Week Low
- BNR $2.18
- DTST $2.93
- 52 Week High
- BNR $7.90
- DTST $6.95
- Technical
- Relative Strength Index (RSI)
- BNR 58.05
- DTST 37.80
- Support Level
- BNR $3.38
- DTST $3.34
- Resistance Level
- BNR $4.19
- DTST $3.82
- Average True Range (ATR)
- BNR 0.41
- DTST 0.18
- MACD
- BNR 0.07
- DTST -0.05
- Stochastic Oscillator
- BNR 61.87
- DTST 11.11
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.